- Home
- CMU vs TIL Comparison
CMU vs TIL Comparison
Compare CMU & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMU
- TIL
- Stock Information
- Founded
- CMU 1987
- TIL 2018
- Country
- CMU United States
- TIL United States
- Employees
- CMU N/A
- TIL N/A
- Industry
- CMU Investment Managers
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- CMU Finance
- TIL Health Care
- Exchange
- CMU Nasdaq
- TIL Nasdaq
- Market Cap
- CMU 85.1M
- TIL 230.1M
- IPO Year
- CMU N/A
- TIL 2021
- Fundamental
- Price
- CMU $3.27
- TIL $24.34
- Analyst Decision
- CMU
- TIL Buy
- Analyst Count
- CMU 0
- TIL 5
- Target Price
- CMU N/A
- TIL $119.00
- AVG Volume (30 Days)
- CMU 82.4K
- TIL 315.0K
- Earning Date
- CMU 01-01-0001
- TIL 08-12-2025
- Dividend Yield
- CMU 4.08%
- TIL N/A
- EPS Growth
- CMU N/A
- TIL N/A
- EPS
- CMU 0.07
- TIL N/A
- Revenue
- CMU N/A
- TIL N/A
- Revenue This Year
- CMU N/A
- TIL N/A
- Revenue Next Year
- CMU N/A
- TIL N/A
- P/E Ratio
- CMU $47.57
- TIL N/A
- Revenue Growth
- CMU N/A
- TIL N/A
- 52 Week Low
- CMU $2.78
- TIL $9.70
- 52 Week High
- CMU $3.38
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- CMU 33.07
- TIL 47.69
- Support Level
- CMU $3.27
- TIL $21.80
- Resistance Level
- CMU $3.34
- TIL $26.91
- Average True Range (ATR)
- CMU 0.02
- TIL 3.52
- MACD
- CMU -0.01
- TIL -0.37
- Stochastic Oscillator
- CMU 10.00
- TIL 35.14
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.